Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. EBIT for the year ending December 31, 2023: USD 843.17 K

Guangdong VTR Bio-Tech Co., Ltd. EBIT is USD 843.17 K for the year ending December 31, 2023, a -95.41% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Guangdong VTR Bio-Tech Co., Ltd. EBIT for the year ending December 31, 2022 was USD 18.36 M, a 338.77% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EBIT for the year ending December 31, 2021 was USD -7.69 M, a -117.68% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EBIT for the year ending December 31, 2020 was USD 43.48 M, a 39.35% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. EBIT for the year ending December 31, 2019 was USD 31.20 M, a 0.25% change year over year.
Key data
Date EBIT EBITDA Net Income EPS (Diluted)
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email